Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results
Global Heart · 05.12.2025 · 20 (1)
DOI: 10.5334/gh.1496 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Global Heart, erschienen am 05.12.2025. Verfasst von Fernando Wyss und 31 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Services and Technology of Guatemala -CARDIOSOLUTIONS, Guatemala. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Influenza Vaccines, Influenza, Human, Pneumococcal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Immunization rates against influenza and pneumococcus in Latin America remain lower than expected, particularly in Andean region, Central America, Mexico, and Caribbean region. An incremental correlation between economic strata and educational level and vaccines uptake has been observed. This highlights the need for more comprehensive data to accurately characterize the current health landscape and develop strategies for improvement. Methods and Design: The Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc Study) is a cross-sectional survey of the general population conducted across 19 Latin American countries. Adults aged 18 years and older completed a 34-question online survey. The pool was validated within the first 1000 responses. Data were grouped into seven categories: demographics, socioeconomic and educational level, cardiometabolic profile, cardiovascular interventions, medical follow-up and treatments, and COVID-19 vaccination status.
Results
A total of 21,389 responses were obtained, distributed as follows: 8915 from the North, Central, and Caribbean region; 7492 from the Andean region; and 4801 from the Southern Cone region. Influenza vaccination rates were lower in the Andean region (OR: 0.62; 95% CI: 0.50–0.78), the Caribbean (OR: 0.30; 95% CI: 0.23–0.39), and Central America (OR: 0.59; 95% CI: 0.46–0.76) compared with the Southern Cone. Residing in Central America (OR: 3.06; 95% CI: 1.62–5.77) was associated with greater pneumococcal vaccination. The probability of being vaccinated against influenza was higher in men (OR: 1.3; 95% CI: 1.1–1.6) and in individuals with obesity (OR: 1.26; 95% CI: 1.13–1.40). COPD was associated with a lower probability of pneumococcal vaccination (OR: 0.51; 95% CI: 0.33–0.79).
Conclusions
This study highlights the importance of targeted vaccination campaigns to improve coverage, particularly in regions with lower rates. It also underscores the need for enhanced education and awareness of the benefits of vaccination. Tackling barriers such as vaccine hesitancy and misinformation will be essential for raising vaccination rates and, ultimately, for reducing the burden of cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Services and Technology of Guatemala -CARDIOSOLUTIONS, Guatemala.
- Hospital Italiano de la Plata, La Plata, Argentina.
- Instituto de Cardiología del Sanatorio Británico, Rosario, Argentina.
- Congenital Heart Disease Department, National Medical Center 21st Century, Mexico.
- University of Ottawa, Faculty of Medicine, Ottawa, Canada.
- Hospital General de Medellín, Medellín, Colombia.
ORCID-Profile: Fernando Wyss, Ricardo Lopez-Santi, Daniel Piskorz, Horacio Márquez Gonzalez, Lucelli Yañez Gutierrez, Shyla Gupta, Ana Munera-Echeverri, Pilar Lopez Santi, Vladimir Ullauri, Juan Esteban Gomez, Mildren Del Sueldo, Claudia Almonte, Máxima Mendez, Osiris Valdez, Carlos Ignacio Ponte-Negretti, María Alayde Mendoça Rivera, Iván Romero Rivera, Adriana Puente Barragan, Raúl Villar, Julio Effio, Jorge Alberto Rivera Pineda, Ana Isabel Barrientos, Nancy Silvera, Edmundo Jordan, Shirley Alejandrina Xiloj Lopez, Daniel Quezada, Gonzalo Perez, Adrián Baranchuk
Zitieren
APA
Wyss, F., Lopez-Santi, R., Piskorz, D., Gonzalez, H. M., Gutierrez, L. Y., Gupta, S., Munera-Echeverri, A., Santi, P. L., Piskorz, G., Ullauri, V., Gomez, J. E., Del Sueldo, M., Almonte, C., Mendez, M., Valdez, O., Ponte-Negretti, C. I., Rivera, M. A. M., Rivera, I. R., Barragan, A. P., …, & Corvacc Study Investigators (2025). Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results. Global Heart, 20(1). https://doi.org/10.5334/gh.1496
Vancouver
Wyss F, Lopez-Santi R, Piskorz D, Gonzalez HM, Gutierrez LY, Gupta S, et al. Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results. Global Heart. 2025;20(1). doi:10.5334/gh.1496
BibTeX
@article{Wyss2025,
author = {Wyss, Fernando and Lopez-Santi, Ricardo and Piskorz, Daniel and Gonzalez, Horacio Márquez and Gutierrez, Lucelli Yañez and Gupta, Shyla and Munera-Echeverri, Ana and Santi, Pilar Lopez and Piskorz, Gonzalo and Ullauri, Vladimir and Gomez, Juan Esteban and Del Sueldo, Mildren and Almonte, Claudia and Mendez, Máxima and Valdez, Osiris and Ponte-Negretti, Carlos Ignacio and Rivera, María Alayde Mendoça and Rivera, Iván Romero and Barragan, Adriana Puente and Villar, Raúl and Effio, Julio and Pineda, Jorge Alberto Rivera and Berrospi, Percy and Barrientos, Ana Isabel and Silvera, Nancy and Jordan, Edmundo and Lopez, Shirley Alejandrina Xiloj and Quezada, Daniel and Arguello, Ariel and Perez, Gonzalo and Baranchuk, Adrián and Corvacc Study Investigators, Corvacc Study Investigators},
title = {Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results},
journal = {Global Heart},
year = {2025},
volume = {20},
number = {1},
doi = {10.5334/gh.1496}
}
EUVIMED